Why the study?
Does the administration of procainamide and mexiletine allow for the prediction of block cycle length based on VT cycle length in patients with sustained ventricular tachycardia?
Does the administration of procainamide and mexiletine allow for the prediction of block cycle length based on VT cycle length in patients with sustained ventricular tachycardia?
While class 1 antiarrhythmic drugs prolong VT and block cycle lengths, the post-medication block cycle length cannot be accurately predicted from baseline ratios, though average ratios may guide initial pacing cycle length selection.
Answers are grounded in this paper and cite their sources.
Cannot accurately predict post-medication block cycle length from baseline VT ratios in individual patients; leaves open whether average ratios guide initial pacing cycle length selection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ohhira et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: